Medicines for treating myopia and preparation method of medicines

Abstract

The invention discloses medicines for treating myopia and a preparation method of the medicines. The medicines comprise niuzijing, golden cicada, semen cassiae, oyster, fructus alpiniae oxyphyllae, Chinese wolfberry fruits, ginseng, radix angelica sinensis, raspberry, mulberries, chrysanthemums, moringa oleifera leaves, mint, xanthophyll, taurine, proanthocyanidins, zinc yeast, chromium yeast, chitosan, and selenium yeast. The medicines are prepared through the steps of performing enzymolysis, performing extraction, performing concentration, and performing low-temperature crushing. After beingtaken, the medicines can supplement qi and replenish blood, can also supplement beneficial components of the xanthophyll, the taurine, the proanthocyanidins, the chitosan, the selenium yeast, the zinc yeast, the chromium yeast, the multiplex vitamin, calcium, amino acid and the like, can provide sufficient nutrients for eyes and the brain, and have efficacy of preventing and treating myopia, amblyopia, astigmatism, asthenopia, benefitting intelligence, and improving memory. The medicines are suitable for students, myopia patients, drivers, and brain workers. The medicines are high in medicineeffect, low in taking amount, easy to absorb by patients, safe to take, convenient to carry, broad in application crowds, and good in effect, and have good market prospects and promotion value.

Description

technical field [0001] The present invention relates to a medicine for treating myopia and a preparation method, more specifically a medicine for treating myopia, amblyopia, astigmatism, astigmatism and improving memory and a preparation method thereof, belonging to the technical field of medicine. Background technique [0002] Myopia, amblyopia, astigmatism, and astigmatism are common eye diseases with extremely high incidence. It is reported that there are 600 million myopia patients in China, ranking first in the world. [0003] Today's treatment of myopia mainly adopts external products such as glasses, physiotherapy instruments, eye patches, massage ointments, eye drops, massage instruments, and eye masks. Oral products sold on the market "lutein tablets", "blueberry lutein tablets", "proanthocyanidin capsules", "grape seed or blueberry extract capsules", "chitin capsules", "taurine milk powder", " "Selenium Treasure Tablets", "Zinc Gluconate Tablets", etc., the raw ma...

AI Technical Summary

Problems solved by technology

The oral products sold on the market are "Lutein Tablets", "Blueberry Lutein Tablets", "Proanthocyanidin Capsules", "Grape Seed or Blueberry Extract Capsules", "Chitin Capsules", "Taurine Milk Powder", " "Selenium Tablets", "Zinc Gluconate Tablets", etc., have a single raw material and are not effective in treating myopia

CN100391475C discloses an ophthalmic peptide injection. Although the injection has a certain clinical effect, it has the following defects: 1. Since there are many nerves around the eye and multi-point injections are required, professional medical personnel are required to operate during the treatment; ②During the treatment, daily injections are required. Because most of the patients are young, they are timid and fearful, and even resist the injection treatment; ③Student patients must often go to professional institutions for injection treatment under the condition of long-term study stress, which brings great inconvenience to the patients; ④The Injections do not have the effect of improving memory; ⑤ The single raw material cannot solve the problems of blood deficiency and Qi deficiency in the human body; ⑥ Long-term decoction at high temperature, the loss and damage of volatile substances or biological enzymes in raw materials are serious

Images